Suppr超能文献

岩骨朗格汉斯细胞组织细胞增多症的放射外科治疗

Petrous bone Langerhans cell histiocytosis treated with radiosurgery.

作者信息

del Río Laura, Lassaletta Luis, Martínez Roberto, Sarriá María Josefa, Gavilán Javier

机构信息

Department of Otolaryngology, La Paz University Hospital, Madrid, Spain.

出版信息

Stereotact Funct Neurosurg. 2007;85(2-3):129-31. doi: 10.1159/000098528. Epub 2007 Jan 12.

Abstract

Langerhans cell histiocytosis (LCH) is a rare disease that may show as a solitary or multifocal lesion of bone, soft tissue or viscera. Involvement of the temporal bone has been described in 15-61% of patients with LCH, usually in association with multisystemic involvement. We report the case of a 30-year-old man presenting with vertigo and fluctuating hearing loss caused by monosystemic LCH of the left petrous bone. The patient was treated with radiosurgery (covering dose 10 Gy at 85% isodose, maximum dose 11.76 Gy). Two years after treatment, no evidence of recurrent disease was found in the CT scan or MRI. We discuss the treatment of temporal bone LCH, traditionally based on surgery, low-dose radiation therapy and intralesional steroids. To our knowledge, this is the first reported case of LCH of the petrous bone successfully treated with radiosurgery. This approach may be interesting in cases of LCH located on nonaccessible areas of the temporal bone.

摘要

朗格汉斯细胞组织细胞增多症(LCH)是一种罕见疾病,可表现为骨、软组织或内脏的孤立性或多灶性病变。颞骨受累在15%至61%的LCH患者中有所描述,通常与多系统受累相关。我们报告一例30岁男性病例,其因左侧岩骨单系统LCH出现眩晕和波动性听力损失。该患者接受了放射外科治疗(85%等剂量线处覆盖剂量10 Gy,最大剂量11.76 Gy)。治疗两年后,CT扫描或MRI未发现疾病复发迹象。我们讨论了颞骨LCH的治疗,传统上基于手术、低剂量放射治疗和病灶内注射类固醇。据我们所知,这是首例成功接受放射外科治疗的岩骨LCH病例。对于位于颞骨难以触及区域的LCH病例,这种方法可能具有吸引力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验